Evidence map›Paper›PMID 35968938›Full record

ArticleClinical and translational medicine2022

Loss of MEN1 leads to renal fibrosis and decreases HGF-Adamts5 pathway activity via an epigenetic mechanism.

Bangming Jin, Jiamei Zhu, Yuxia Zhou, Li Liang, Yunqiao Yang, Lifen Xu, Tuo Zhang, Po Li, Ting Pan, Bing Guo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Bangming JinDepartment of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.ORCID https://orcid.org/0000-0002-2997-5587
Jiamei ZhuSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Yuxia ZhouDepartment of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Li LiangSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Yunqiao YangSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Lifen XuDepartment of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Tuo ZhangSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Po LiDepartment of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Ting PanSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Bing GuoSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Tengxiang ChenDepartment of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Haiyang LiDepartment of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Guiyang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal fibrosis is a serious condition that results in the development of chronic kidney diseases. The MEN1 gene is an epigenetic regulator that encodes the menin protein and its role in kidney tissue remains unclear.

methodsKidney histology was examined on paraffin sections stained with hematoxylin-eosin staining. Masson's trichrome staining and Sirius red staining were used to analyze renal fibrosis. Gene and protein expression were determined by quantitative real-time PCR (qPCR) and Western blot, respectively. Immunohistochemistry staining in the kidney tissues from mice or patients was used to evaluate protein levels. Flow cytometry was used to analyze the cell cycle distributions and apoptosis. RNA-sequencing was performed for differential expression genes in the kidney tissues of the Men1f/f and Men1∆/∆ mice. Chromatin immunoprecipitation sequencing (ChIP-seq) was carried out for identification of menin- and H3K4me3-enriched regions within the whole genome in the mouse kidney tissue. ChIP-qPCR assays were performed for occupancy of menin and H3K4me3 at the gene promoter regions. Luciferase reporter assay was used to detect the promoter activity. The exacerbated unilateral ureteral obstruction (UUO) models in the Men1f/f and Men1∆/∆ mice were used to assess the pharmacological effects of rh-HGF on renal fibrosis.

resultsThe expression of MEN1 is reduce in kidney tissues of fibrotic mouse and human diabetic patients and treatment with fibrotic factor results in the downregulation of MEN1 expression in renal tubular epithelial cells (RTECs). Disruption of MEN1 in RTECs leads to high expression of α-SMA and Collagen 1, whereas MEN1 overexpression restrains epithelial-to-mesenchymal transition (EMT) induced by TGF-β treatment. Conditional knockout of MEN1 resulted in chronic renal fibrosis and UUO-induced tubulointerstitial fibrosis (TIF), which is associated with an increased induction of EMT, G2/M arrest and JNK signaling. Mechanistically, menin recruits and increases H3K4me3 at the promoter regions of hepatocyte growth factor (HGF) and a disintegrin and metalloproteinase with thrombospondin motifs 5 (Adamts5) genes and enhances their transcriptional activation. In the UUO mice model, exogenous HGF restored the expression of Adamts5 and ameliorated renal fibrosis induced by Men1 deficiency.

conclusionsThese findings demonstrate that MEN1 is an essential antifibrotic factor in renal fibrogenesis and could be a potential target for antifibrotic therapy.

Indexed as

Kidney DiseasesUreteral ObstructionADAMTS5 ProteinAnimalsApoptosisCell Line, TumorEpigenesis, GeneticFibrosisG2 Phase Cell Cycle CheckpointsHepatocyte Growth FactorHumansMiceProto-Oncogene ProteinsADAMTS5 ProteinADAMTS5 protein, humanAdamts5 protein, mouseHepatocyte Growth FactorHGF protein, humanMen1 protein, mouseProto-Oncogene Proteinsepigenetic mechanismepithelial-to-mesenchymal transition (EMT)H3K4me3MEN1 generenal fibrosis

Identifiers

PMID35968938
PMCPMC9377152
OpenAlexW4291536851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.